Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2032

Annual patent cliff calendar for 2032 — US pharmaceutical patents by expiration date.

Patents
1,150

Quick answer

1,150 indexed pharmaceutical patents have expiration dates in 2032. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 8273709

    Triazole-containing macrocyclic HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8273741

    Imidazo-pyridazinyl compounds and uses thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8273729

    Treatment of irritable bowel syndrome and related bowel disease

    The Board of Regents of the University of Texas System · Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8273750

    Organic compounds

    Takeda Pharmaceutical Company Limited · Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8273751

    Organic compounds

    Takeda Pharmaceutical Company Limited · Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8273761

    Tricyclic compound and medical use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8273786

    3-phenoxymethylpyrrolidine compounds

    Theravance, Inc. · Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8273797

    Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8273833

    Branched Polymers

    Nektar Therapeutics · Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8273867

    Transducible delivery of siRNA by dsRNA binding domain fusions to PTD/CPPS

    The Regents of the University of California · Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8273868

    Compositions and methods for inhibiting viral replication

    Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8273869

    Lipid formulated dsRNA targeting the PCSK9 gene

    Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8273870

    Compositions and methods for inhibiting expression of a mutant gene

    Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8273896

    Processes for producing phenyl-6-(1-(phenyl)ureido)nicotinamides

    Vertex Pharmaceuticals Incorporated · Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8274643

    Porous nanostructures and methods involving the same

    The Regents of the University of California · Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8275594

    Engineered scaffolds for intervertebral disc repair and regeneration and for articulating joint repair and regeneration

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8277831

    Drug-enhanced adhesion prevention

    Advanced Technologies and Regenerative Medicine, LLC · Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8278084

    Aminopyridine dimer compounds, compositions and related methods for neuronal nitric oxide synthase inhibition

    Northwestern University · Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8278450

    Kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8278305

    Myosin light chain kinase inhibitor compounds, compositions and related methods of use

    Northwestern University · Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8278100

    Lasonolide compounds as reagents for inducing premature chromosome condensation and methods for treating disorders

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8278437

    Hydroxypropyl-sulfobutyl-beta-cyclodextrin, the preparation method, the analytical method, and the pharmacutical application thereof

    Hainan Hdeton Science and Technology Co., Ltd. · Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8278458

    Desferrithiocin polyether analogues

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8277796

    Regeneration and repair of neural tissue using postpartum-derived cells

    Advanced Technologies and Regenerative Medicine, LLC · Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8278083

    Inactivated influenza virus compositions

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8278297

    Protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8278306

    C-met protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8278299

    Pyrimidinediamine kinase inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8278293

    Diazo bicyclic Smac mimetics and the uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8278348

    Chondropsin-class antitumor V-atpase inhibitor compounds, compositions and methods of use thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8278272

    GLP-1, exendin-4, peptide analogs and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8277798

    Use of cells containing a specific DNA molecule as cytopathic agents to inhibit the proliferation of cells

    Bayerische Julius-Maximilians-Universität Würzburg · Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8278246

    Biocontrol of storage maladies of potatoes by bacterial antagonists produced in co-culture

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8278085

    RNA processing protein complexes and uses thereof

    PTC THERAPEUTICS, INC. · Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8277797

    Interferon-β production modulating Listeria strains and methods for using same

    The Regents of the University of California · Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8282926

    CCR5-specific antibodies with HIV neutralizing activity that recognize a linear dodecapeptide that mimics a conformational epitope in the second extracellular loop of CCR5

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8283114

    Genes of an otitis media isolate of nontypeable Haemophilus influenzae

    The Board of Regents of the University of Oklahoma · Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8283342

    Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor

    Almirall, S.A. · Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8282963

    Methods for extracting platelets and compositions obtained therefrom

    The Regents of the University of Colorado, a Body Corporate · Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8283377

    Method for inhibiting blood vessel stenosis

    China Medical University · Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8283353

    Fused ring compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8283461

    Multiple promoter expression cassettes for simultaneous delivery of RNAi agents

    Benitec, Inc. · Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8283458

    VMP-like sequences of pathogenic Borrelia species and strains

    The Board of Regents of the University of Texas System · Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8283370

    Imidazolidinedione derivatives as antimalarial agents, preparation thereof, and methods of use

    The United States of America as represented by the Secretary of the Army · Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8283368

    Selective ligands for the dopamine 3 (D3) receptor and methods of using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8283309

    Bridged carbocyclic oxime hepatitis C virus serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8283151

    Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8282937

    Cold-adapted (CA) reassortant influenza virus

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2032?

1,150 published patents in our USPTO index have expiration dates falling in calendar year 2032.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.